0001752724-22-062869.txt : 20220316 0001752724-22-062869.hdr.sgml : 20220316 20220316155929 ACCESSION NUMBER: 0001752724-22-062869 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220316 DATE AS OF CHANGE: 20220316 EFFECTIVENESS DATE: 20220316 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HIGHLAND INCOME FUND\MA CENTRAL INDEX KEY: 0001710680 IRS NUMBER: 456245636 STATE OF INCORPORATION: MA FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-23268 FILM NUMBER: 22744803 BUSINESS ADDRESS: STREET 1: 2515 MCKINNEY AVENUE STREET 2: SUITE 1100 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 833-697-6246 MAIL ADDRESS: STREET 1: 2515 MCKINNEY AVENUE STREET 2: SUITE 1100 CITY: DALLAS STATE: TX ZIP: 75201 FORMER COMPANY: FORMER CONFORMED NAME: HIGHLAND FLOATING RATE OPPORTUNITIES FUND DATE OF NAME CHANGE: 20170925 FORMER COMPANY: FORMER CONFORMED NAME: HIGHLAND FLOATING RATE OPPORTUNITIES FUND II DATE OF NAME CHANGE: 20170628 N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001710680 XXXXXXXX 811-23268 N-2 HIGHLAND INCOME FUND\MA 811-23268 0001710680 254900CMUE9FRYL2UR80 2515 McKinney Avenue Suite 1100 DALLAS 75201 US-TX US 972-934-4700 SEI Investments Global Funds Services 1 Freedom Valley Drive Oaks 19456 1-610-676-1000 Records as Administrator for Trust Highland Capital Management Fund Advisors, L.P. 300 Crescent Court Suite 700 Dallas 75201 1-877-665-1287 Records as Advisor and Administrator for Trust The Bank of New York Mellon 240 Greenwich Street New York 10286 1-212-495-1784 Records as Custodian for Trust NexPoint Securities, Inc. 300 Crescent Court Suite 700 Dallas 75201 1-972-628-4100 Records as Distributor for Trust American Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn 11219 1-800-937-5449 Records As Transfer Agent For Trust N N N-2 Y Ethan Powell N/A N Pamela Corrie N/A N Bryan A. Ward N/A N John Honis N/A Y Dr. Bob Froehlich N/A N Stephanie Vitiello N/A 200 Crescent Court, Suite 700 Dallas 75201 XXXXXX N N N N NexPoint Securities, Inc. 8-69128 000165013 N/A Y N Cohen & Company, Ltd. 925 N/A N N N N N N Highland Income Fund 254900CMUE9FRYL2UR80 N 0 0 0 N/A Y N Y N N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N N/A 909920.40 18213.35 Rule 17a-6 (17 CFR 270.17a-6) Rule 23c-1 (17 CFR 270.23c-1) Rule 32a-4 (17 CFR 270.32a-4) Rule 12d1-1 (17 CFR 270.12d1-1) Rule 17a-7 (17 CFR 270.17a-7) N N N N Highland Capital Management Fund Advisors, L.P. 801-69968 000149653 5493002K2NSYVU046L11 N American Stock Transfer & Trust Company, LLC 084-00416 254900TS5EWP83BEOU02 N N N Pricing Direct 549300WIC0TOJ7N7GD54 N IHS Markit 549300HLPTRASHS0E726 GB N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N Thomson Reuters Corporation 549300561UZND4C7B569 CA N S&P 549300U4VWNITEKO2881 N Bloomberg 254900BF4G8VMW8GG471 N N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N American Stock Transfer & Trust Company, LLC 254900TS5EWP83BEOU02 N N N SEI INVESTMENTS GLOBAL FUNDS SERVICES 801-24593 SEC FILE NUMBER N N Highland Capital Management Fund Advisors, L.P. 5493002K2NSYVU046L11 Y N N NexPoint Securities, Inc. 8-69128 000165013 N/A 0.00 JONES TRADING 008-26089 000006888 213800DIYIKDWRCFOC55 3316.84 STIFEL NICOLAUS & CO., INC. 008-01447 000000793 5WUVMA08EYG4KEUPW589 7030.16 RAYMOND JAMES 008-10999 000000705 U4ONQX15J3RO8XCKE979 5272 FRIEDMAN BILLINGS & RAMSEY 008-41426 000025027 549300AEVMODVBY3QS51 62231.96 SOCIETE GENERALE COWEN SECURITIES CORP. 008-40756 000023857 5493008QI0EFC5WBED75 6497.5 JONES & ASSOCIATES 8-26089 000106861 N/A 34384.35 NEWEDGE CANADA N/A N/A N/A CA 4050 NEW EDGE 008-66125 000128351 549300F35UE0BOM1WJ55 6220 MKM PARTNERS 8-50311 000043552 54930015ODYESNP2QX15 15050.26 NEWEDGE USA, LLC 008-66125 000128351 549300F35UE0BOM1WJ55 9170.9 159474.65 BONY 008-35303 000017481 N/A 78012067.74 GFI SECURITIES LTD LONDON N/A N/A GUNTJCA81C7IHNBGI392 GB 12298220 MIZUHO SECURITIES 008-37710 000019647 7TK5RJIZDFROZCA6XF66 10880000 BROWNSTONE 8-29349 000014055 N/A 40768450.75 BREAN CAPITAL, LLC 8-40742 000023723 254900ZZA1UBVDCNQ378 15853812.50 CANTOR FITZGERALD & CO. 008-00201 000000134 5493004J7H4GCPG6OB62 15229092.64 NOMURA 008-15255 000004297 OXTKY6Q8X53C9ILVV871 16778450 NATIONAL ALLIANCE CAPITAL, LLC 8-48723 000039455 N/A 9445214.53 JPM CHASE 008-35008 000000079 ZBUT11V806EZRVTWT807 8969429.20 BAIRD, ROBERT W., & CO., INCORPORATED 008-00497 000008158 549300772UJAHRD6LO53 21247036.55 523957430.7 N 973618157.17 Other Common Common stock N N Common stock N N N 0.74 0.0167 10.99 14.29 true false true false false false LEGAL PROCEEDINGS 2 HFRO_G.1.a.txt LEGAL PROCEEDINGS Highland Income Fund Item G.1.a.i. - Legal Proceedings Two affiliated funds, including the Highland Income Fund (f/k/a Highland Floating Rate Opportunities Fund), are the beneficiaries of an approximately $122 million judgment against Credit Suisse related to a syndicated real estate transaction fraudulently underwritten by the Swiss bank. The judgment was appealed up to the Dallas Court of Appeals, then the Texas Supreme Court, remanded to the trial court, and is back to the Dallas Court of Appeals. The two funds also are participants in a similar action against Credit Suisse related to five additional real estate deals in which the funds allege Credit Suisse committed fraud in relation to the underwriting. INTERNAL CONTROL RPT 3 HFRO_ICL.txt INTERNAL CONTROL LETTER REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders and Board of Trustees of Highland Income Fund In planning and performing our audit of the consolidated financial statements of Highland Income Fund (the Fund) as of and for the year ended December 31, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the consolidated financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds internal control over financial reporting. Accordingly, we express no such opinion. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A funds internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles (GAAP). A funds internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and trustees of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a funds assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Funds annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Funds internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of December 31, 2021. This report is intended solely for the information and use of management and the Board of Trustees of the Fund and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. COHEN & COMPANY, LTD. Cleveland, Ohio March 04, 2022